![Jan Kruse Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Kruse Hansen
Directeur Général chez Australian Bodycare Continental 2012 ApS
Profil
Jan Kruse Hansen has worked as a Chief Executive Officer at Astion Pharma A since 2018 and as a Managing Director & Director at Australian Bodycare Continental 2012 ApS since 2015.
Postes actifs de Jan Kruse Hansen
Sociétés | Poste | Début |
---|---|---|
Australian Bodycare Continental 2012 ApS
![]() Australian Bodycare Continental 2012 ApS Specialty StoresRetail Trade Australian Bodycare Continental 2012 ApS supplies personal care products based on tea tree oil. It offers hair products, facial creams, facial scrubs and wash, body wash products, body lotions, sun creams, and skin clarifiers. The company was founded in 1992 and is headquartered in Vissenbjerg, Denmark. | Directeur Général | 01/09/2015 |
Astion Pharma A/S
![]() Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Directeur Général | 01/09/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Australian Bodycare Continental 2012 ApS
![]() Australian Bodycare Continental 2012 ApS Specialty StoresRetail Trade Australian Bodycare Continental 2012 ApS supplies personal care products based on tea tree oil. It offers hair products, facial creams, facial scrubs and wash, body wash products, body lotions, sun creams, and skin clarifiers. The company was founded in 1992 and is headquartered in Vissenbjerg, Denmark. | Retail Trade |
Astion Pharma A/S
![]() Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Health Technology |